We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Large Fungal Spores Are More Virulent for Immunosuppressed Patients

By LabMedica International staff writers
Posted on 23 Jun 2011
Print article
Image: A sexual spore (zygospore) of the human pathogenic zygomycete, Mucor circinelloides. (Photo courtesy of Valerie Knowlton, NC State University).
Image: A sexual spore (zygospore) of the human pathogenic zygomycete, Mucor circinelloides. (Photo courtesy of Valerie Knowlton, NC State University).
Two different spore sizes of the fungus Mucor circinelloides, a pathogen that kills half or more of its victims, could help to categorize these fungal infections, develop new treatments, and fight other types of fungal infections.

Scientists at the department of molecular genetics and microbiology, Duke University Medical Center (Durham, NC, USA) demonstrated the new way to categorize fungi. A fungus is typically described through its growth pattern: either fingerlike hyphal growth, like bread mold, or round and symmetric isotropic growth, like an expanding balloon. The scientists at Duke concluded from their study that there is another way to categorize a fungus, by whether it produces larger or smaller spores. The work was published in PLoS Pathogens online on June 16, 2011.

Mucor infection was in the news as an environmental fungus contracted by people who had trauma in the wake of tornadoes in Joplin (MO, USA). Three out of eight patients had died by June 11. This group of fungi can be common in the environment but only particular hosts with high risks become infected. In Joplin, some people got the fungal infection through traumatic skin wounds.

"Clinically, these mucor infections are reasonably common in diabetic patients, transplant patients, and lung-cancer chemotherapy patients," said Joseph Heitman, MD, PhD, cosenior author and chair of the Duke department of molecular genetics and microbiology, said. "Having a high blood-glucose level is immunosuppressive, and predisposes diabetic patients to difficult-to-manage fungal infections."

Related Links:
Department of Molecular Genetics and Microbiology, Duke University Medical Center

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.